Acute exacerbations of chronic obstructive pulmonary disease (COPD) are serious complications of this condition. Reducing their frequency and severity is a major goal in COPD management. Bacterial ...

Please provide your email address to receive an email when new articles are posted on . Patients receiving roflumilast vs. azithromycin had a reduced risk for COPD exacerbations at 1 year but an ...

Jorgen Vestbo, MD, on the COPERNICOS trial results, long-term antibiotic use versus resistance concerns, and where COPD treatment is headed. The COPERNICOS (NCT04481555) trial, a multicenter, ...

Please provide your email address to receive an email when new articles are posted on . Azithromycin added to inhaled triple therapy in those with COPD and a recent exacerbation history was ...

Chronic obstructive pulmonary disease (COPD) is the fourth-leading cause of death worldwide and a major risk factor for lung cancer - and it's becoming more common in women, even those who are younger ...

A review gives an overview of potential biomarkers in chronic obstructive pulmonary disease. In a recently published review, researchers outlined the background research and results of clinical trials ...

We’ve all been more aware of lung health since Covid-19. However, for people with asthma and chronic obstructive pulmonary disease (COPD), dealing with lung problems is a lifelong struggle. Those with ...